admin

While federal, state and local policies aim to support entrepreneurs through grants and tax breaks that make capital more easily attainable, the latest Entrepreneurship Policy Digest released by the Kauffman Foundation, America’s leading entrepreneurship think-tank, says entrepreneurs most often turn to two forms of private external financing: debt and equity.

The Policy Digest says debt is the most common source of financing for new businesses, with about 40% of a business’ initial startup capital coming from bank-financed debt. Equity is a less common form of initial funding, according to the Digest, with less than 3% of new firms funded by angel investors and less than 1% funded by venture capitalists.

Chancellor Brit Kirwan reflects on the progress the University System of Maryland (USM) has made during his tenure as chancellor. He expresses gratitude to the USM community for the work it has done to elevate the quality of USM education, fuel the state’s economic development, and establish USM as a national model for higher education.

To this day, the CEO of Bethesda-based GetWellNetwork Inc. still can’t stand the smell of Domino’s pizza.

“It smells like chemo,” Michael O’Neil said of what used to be his favorite meal, until he was treated for non-Hodgkin lymphoma more than 15 years ago.

In recent years, the applications for 3D printing in healthcare have been expanding into the limitless. Once reserved primarily for prototyping, the technology has quickly proliferated in the life sciences – with applications that range from personalized surgical implants, scaffolding and tissue generation.

The 3D printing market in healthcare will reach $4 billion by 2018, according to a report from British market research firm Visiongain. The most well-known use of 3D printing may be Organovo, the publicly traded San Diego company that likens cells to ink in a 3D printing process that builds live human tissue.

The University of Maryland has been named to the 2015 class of Innovation & Economic Prosperity Universities by the Association of Public and Land-grant Universities (APLU). The designation honors 18 universities working with public and private sector partners in their states and regions to support economic development through a variety of activities, including innovation and entrepreneurship, technology transfer, talent and workforce development, and community development.  

“Public universities serve as economic engines for their local communities and states by conducting cutting edge research to reach new breakthroughs and developing the talent to help existing businesses grow stronger and enabling new ones to develop and thrive,” said APLU President Peter McPherson. “The 18 institutions in the 2015 class of Innovation & Economic Prosperity Universities serve as wonderful models of how public research universities extend beyond their campuses to engage their communities in economic development that create jobs and improve lives.” 

Department of Health and Human Services Secretary Sylvia M. Burwell today announced the seven winners of the 2015 HHS Innovates Awards. This annual award program, in its eighth round, recognizes creative solutions developed by HHS employees in response to some of the nation’s most challenging problems in health, health care and government. Winners this year reflected a number of collaborative innovation projects representing seven different operating divisions (winners listed below).

For many sea creatures, regrowing a lost limb is routine. But when a young jellyfish loses a tentacle or two to the jaws of a sea turtle, for example, it rearranges its remaining limbs to ensure it can still eat and swim properly, according to a new study published June 15 in Proceedings of the National Academy of Sciences. The discovery should excite marine enthusiasts and roboteers alike, the authors say, because the jellyfish’s strategy for self-repair may teach investigators how to build robots that can heal themselves. “It’s another example of nature having solved a problem that we engineers have been trying to figure out for a long time,” says John Dabiri, a biophysicist at Stanford University who had discussed the project with the study investigators but was not involved with the research.

GlycoMimetics, Inc. (NASDAQ: GLYC) announced today that Pfizer Inc. (NYSE: PFE) has dosed the first patient in the RESET (Rivipansel: Evaluating Safety, Efficacy and Time to Discharge) study – a Phase 3 clinical trial assessing the efficacy and safety of rivipansel for the treatment of vaso-occlusive crisis (VOC) in patients hospitalized with sickle cell disease who are six years of age or older. The start of this trial triggered the second of two milestone payments from Pfizer to GlycoMimetics totaling $35 million for Phase 3 initiation. GlycoMimetics received a $15 million milestone payment from Pfizer in May 2014.

The global population is aging as life expectancy increases. That means not only is demand for healthcare rising, but the very nature of that care is changing. In this interview, the CEO of Swiss pharmaceutical company Novartis, Joseph Jimenez, discusses with McKinsey’s Rik Kirkland issues including the emerging need for regenerative medicine, how digitization is driving innovation, and why Novartis is shifting to an outcomes-based approach for patient treatments. An extended and edited transcript of Jimenez’s remarks follows.

The Mayo Clinic’s Jacksonville, Florida unit and Silver Spring, Maryland-based biotechnology company United Therapeutics Corporation have announced that they will collaborate on construction and operation of a lung restoration center to be located on Mayo’s Jacksonville campus. The project’s goal is to significantly increase the volume of lungs available for transplants for a range of patients with various lung diseases, including those with PAH, by preserving and restoring selected marginal donor lungs, thereby making them viable for transplantation.